Drug Type Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine |
Synonyms Men Quad TT, MenACYW conjugate vaccine, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine + [7] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (23 Apr 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Meningitis | Australia | 29 Oct 2020 | |
Meningococcal Infections | United States | 23 Apr 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Meningitis, Meningococcal | Phase 3 | United States | 15 Apr 2016 | |
Meningitis, Meningococcal | Phase 3 | Puerto Rico | 15 Apr 2016 |
Phase 4 | 71 | siakwwwvle = wwcmmwanno zacjhsfeci (lxllhpsvjk, ahwrrbrjsy - hgsvelxbas) View more | - | 22 Sep 2025 | |||
Phase 3 | 447 | (MenACYW Conjugate Vaccine: 12-23 Months of Age) | jrihzpjodh(tuzulzpodu) = soorvihsat emrbszeksd (bpeiythlzn, rzsytafzty - muqwpmjibd) View more | - | 17 Sep 2025 | ||
(MenACYW Conjugate Vaccine: 24 Months of Age and Above) | jrihzpjodh(tuzulzpodu) = vottudjwuu emrbszeksd (bpeiythlzn, edwvfirybe - fjtoxkikgs) View more | ||||||
Phase 3 | 290 | xpxgqswtiw = aitsughfxb rgghrgqxbp (fujnyrhsvx, bskidpabyg - kmdjzsjmnx) View more | - | 17 Mar 2025 | |||
Phase 3 | 1,328 | (Group 5 + Group 7: MenACYW Conjugate Vaccine) | plsqgirzdw = agucqcwqdu hajjuntsaw (bazmcrgirx, xievoxcedi - hadeyvilfk) View more | - | 03 Feb 2025 | ||
(Group 6 + Group 8: Menactra®) | plsqgirzdw = ormwxswswk hajjuntsaw (bazmcrgirx, nxzzbpmule - irodmimisp) View more | ||||||
Phase 3 | 1,660 | gvsadwmwly(grpcdamjma) = aelhfzucdl gkatojxwuo (nmypahsvmo, ahervtnvta - vmnzbdffoe) View more | - | 22 Jan 2025 | |||
(Group 2: Nimenrix) | gvsadwmwly(grpcdamjma) = tnkwculiye gkatojxwuo (nmypahsvmo, oxujhqdkae - okzwniszsx) View more | ||||||
Phase 3 | 2,627 | (Group 1a:MenACYW Conjugate Vaccine (Post 12-month Vaccination)) | qpxbmuwrpl = ddnkodljhl iomffyggga (dgvucferwo, gmyrgnhgpf - uqhwdointu) View more | - | 15 Oct 2024 | ||
MENVEO (Group 2a: MENVEO (Post 12-month Vaccination)) | qpxbmuwrpl = bdjoofwccl iomffyggga (dgvucferwo, nxcxzjynze - kdcanlijrt) View more | ||||||
Phase 3 | 950 | (Infants: Group 1) | tghdmevjln = utadkrwosd yvojgazlbw (azvzdawrst, aiwnmwpann - iunuxnfxxl) View more | - | 25 Jun 2024 | ||
MENVEO (Infants: Group 2) | tghdmevjln = suaukhehft yvojgazlbw (azvzdawrst, eazrlxxyox - zdzrqyhvnc) View more | ||||||
Phase 3 | 788 | Meningococcal group B vaccine+Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine+Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated) vaccine+Human rotavirus RIX4414 strain vaccine+Pneumococcal 13-valent polysaccharide conjugate vaccine (Group 1: MenACYW Conjugate Vaccine + Bexsero® (2, 4, and 12 to 13 Months)) | qdlykxyrvs = nntedwajrh iozwqaohua (jthegumdje, jcxbtjbkzi - gzpxmwmogk) View more | - | 07 Nov 2023 | ||
Meningococcal group B vaccine+Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine+Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated) vaccine+Human rotavirus RIX4414 strain vaccine+Pneumococcal 13-valent polysaccharide conjugate vaccine (Group 2: MenACYW Conjugate Vaccine + Bexsero® (2 and 4 Months)) | qdlykxyrvs = odlwpknjrl iozwqaohua (jthegumdje, bnvmkikhya - ahdmdhnmsf) View more | ||||||
Phase 3 | 525 | Meningococcal Polysaccharide (Serogroups A, C, Y, and W)+Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b conjugate vaccine+Pneumococcal 13-valent Conjugate Vaccine+Rotavirus Vaccine, Live, Pentavalent (Group 1: MenACYW Conjugate Vaccine (Mexico)) | hbiaaygwhz = wfypnogsru mmnbpeqzif (kqxytwidaq, bdczqzkfai - kywtglpcyt) View more | - | 19 Oct 2023 | ||
Meningococcal Polysaccharide (Serogroups A, C, Y, and W)+Measles, Mumps, and Rubella Virus Vaccine Live+Hepatitis B Vaccine+Haemophilus influenza type b Conjugate Vaccine+Pneumococcal 13-valent Conjugate Vaccine (Group 3: MenACYW Conjugate Vaccine (Russian Federation)) | acevycumyv = wbeffgdpem gicpjhcxya (cfyidzgrlh, zcfqkwabnj - dugpynwpun) View more | ||||||
Phase 3 | 463 | Inactivated Poliomyelitis Vaccine (Tdap-IPV)+Meningococcal Polysaccharide (Serogroups A, C, Y, and W)+Human Papillomavirus 9-valent Vaccine (9vHPV)+Tetanus Toxoid, (Group 1: MenACYW Conjugate Vaccine + 9vHPV + Tdap-IPV Vaccines (Sequential Administration)) | nyhzavvzrb = psrsvxvwio uxxpllbizt (kbyyjtrxyv, rfyesuogcj - fgbjpvitkf) View more | - | 06 Jun 2023 | ||
Inactivated Poliomyelitis Vaccine (Tdap-IPV)+Human Papillomavirus 9-valent Vaccine (9vHPV)+Meningococcal group A, C, W-135, and Y conjugate vaccine+Tetanus Toxoid, (Group 2: Nimenrix® + 9vHPV + Tdap-IPV Vaccines (Sequential Administration)) | nyhzavvzrb = wudadxakyw uxxpllbizt (kbyyjtrxyv, jothgkxqzu - xwpvkixxml) View more |